-+ 0.00%
-+ 0.00%
-+ 0.00%

Tonix Pharmaceuticals To Present Effects Of TONMYA On Fibromyalgia Symptoms And Physical Function At The World Congress On Pain, October 26-30

Benzinga·10/19/2026 11:14:24
Listen to the news

TONMYA was approved by the U.S. Food and Drug Administration on August 15, 2025, and commercially launched in the U.S. on November 17, 2025.

Poster Presentation Details

Title: Cyclobenzaprine HCl Sublingual Reduces Fibromyalgia Impact on Physical Symptoms & Functional Ability

Poster #: 157

Poster Session: 2

Date: October 27, 2026

Time: 3:15-4:45 p.m. ICT

Presenter: Errol Gould, Ph.D., Senior Vice President, Medical Affairs, Tonix Medicines